CDKN1A and cancer: We noted the rapid binding of DNA-PKCS to both distal and proximal p21 promoters under pro-death (DNA damage conditions chromium or gemcitabine) but not pro-arrest conditions (doxorubicin or IR) in a range of model cancer cell lines (Fig. 4A, S5A and S5B).